• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: AMO MANUFACTURING NETHERLANDS BAERVELDT SHUNT; IMPLANT, EYE VALVE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

AMO MANUFACTURING NETHERLANDS BAERVELDT SHUNT; IMPLANT, EYE VALVE Back to Search Results
Model Number BG103-250
Medical Device Problem Code Adverse Event Without Identified Device or Use Problem (2993)
Health Effect - Clinical Codes Eye Injury (1845); Inflammation (1932); Red Eye(s) (2038); Excessive Tear Production (2235)
Type of Reportable Event Serious Injury
Additional Manufacturer Narrative
Unknown; requested but not provided.Date of event: unknown; requested but not provided.The best estimate date is between (b)(6) 2021 and (b)(6) 2023.Section d6b: if explanted, give date: unknown, information was requested but not provided.The best estimate date is may 2022.The device was not returned for evaluation; therefore, a failure analysis of the complaint device cannot be completed.A review of the device history record, complaint trending, and risk documentation for this device will be performed.Upon completion of the review, if there is any further relevant information a supplemental medwatch will be filed.Multiple attempts have been made to obtain additional information regarding the event; however, to date, no response has been received.All pertinent information available to johnson & johnson surgical vision, inc.Has been submitted.
 
Event or Problem Description
It was reported that after the glaucoma implant was implanted on (b)(6) 2021, it was then removed in may 2022.The patient is experiencing inflammation, irritation, and constant watering of the eye.The patient believes the body has rejected the implant.The patient is currently under treatment with the same implanting physician and on the following medications: prednisone for 3 days; eorzolamieehci ,timololmaleate; bromfenac solution.The patient reported having permanent eye and optic damage and is suggesting that it might be the implant.No further information was provided.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
BAERVELDT SHUNT
Common Device Name
IMPLANT, EYE VALVE
Manufacturer (Section D)
AMO MANUFACTURING NETHERLANDS
van swietenlaan 5
groningen, groningen 9728 NX
NL  9728 NX
Manufacturer Contact
somyata nagpal
31 technology drive
irvine, CA 92618
7142478552
MDR Report Key16401660
Report Number3012236936-2023-00386
Device Sequence Number5705746
Product Code KYF
UDI-Device Identifier05050474513013
UDI-Public(01)05050474513013(17)220423
Combination Product (Y/N)N
Initial Reporter CountryUS
PMA/510(K) Number
K905129
Number of Events Summarized1
Summary Report (Y/N)N
Device Implanted Year2021
Serviced by Third Party (Y/N)N
Reporter Type Manufacturer
Report Source Consumer
Initial Reporter Occupation Non-Healthcare Professional
Type of Report Initial
Report Date (Section B) 02/17/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Operator of Device Health Professional
Device Expiration Date04/23/2022
Device Model NumberBG103-250
Device Catalogue Number23030819
Was Device Available for Evaluation? No
Was the Report Sent to FDA? No
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 01/25/2023
Initial Report FDA Received Date02/20/2023
Was Device Evaluated by Manufacturer? (Y/N) Device Not Returned to Manufacturer
Date Device Manufactured04/23/2020
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Outcome Attributed to Adverse Event Required Intervention;
Patient SexMale
-
-